Quent Long Short Global Small Cap Fund, LP Regeneron Pharmaceuticals, Inc. Transaction History
Quent Long Short Global Small Cap Fund, LP
- $1.16 Billion
- Q4 2025
A detailed history of Quent Long Short Global Small Cap Fund, LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Quent Long Short Global Small Cap Fund, LP holds 478 shares of REGN stock, worth $331,493. This represents 0.03% of its overall portfolio holdings.
Number of Shares
478Holding current value
$331,493% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,521Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...